225 related articles for article (PubMed ID: 20564423)
1. Phenoxodiol inhibits growth of metastatic prostate cancer cells.
Aguero MF; Venero M; Brown DM; Smulson ME; Espinoza LA
Prostate; 2010 Aug; 70(11):1211-21. PubMed ID: 20564423
[TBL] [Abstract][Full Text] [Related]
2. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H
Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271
[TBL] [Abstract][Full Text] [Related]
3. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1.
Aguero MF; Facchinetti MM; Sheleg Z; Senderowicz AM
Cancer Res; 2005 Apr; 65(8):3364-73. PubMed ID: 15833870
[TBL] [Abstract][Full Text] [Related]
4. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
5. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
6. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
Hadaschik BA; Ettinger S; Sowery RD; Zoubeidi A; Andersen RJ; Roberge M; Gleave ME
Int J Cancer; 2008 May; 122(10):2368-76. PubMed ID: 18240145
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
Choi ES; Shim JH; Jung JY; Kim HJ; Choi KH; Shin JA; Nam JS; Cho NP; Cho SD
Cancer Sci; 2011 Apr; 102(4):742-8. PubMed ID: 21241418
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
Mori A; Lehmann S; O'Kelly J; Kumagai T; Desmond JC; Pervan M; McBride WH; Kizaki M; Koeffler HP
Cancer Res; 2006 Mar; 66(6):3222-9. PubMed ID: 16540674
[TBL] [Abstract][Full Text] [Related]
9. A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3.
Shi M; Zhou X; Zhang Z; Wang M; Chen G; Han K; Cao B; Liu Z; Mao X
Toxicol Lett; 2014 Aug; 228(3):133-9. PubMed ID: 24831963
[TBL] [Abstract][Full Text] [Related]
10. Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria.
Bemis DL; Capodice JL; Gorroochurn P; Katz AE; Buttyan R
Int J Oncol; 2006 Nov; 29(5):1065-73. PubMed ID: 17016636
[TBL] [Abstract][Full Text] [Related]
11. Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression.
Barboro P; Ferrari N; Capaia M; Petretto A; Salvi S; Boccardo S; Balbi C
Int J Cancer; 2015 Oct; 137(7):1574-86. PubMed ID: 25808111
[TBL] [Abstract][Full Text] [Related]
12. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells.
Chang SH; Bae JH; Hong DP; Choi KD; Kim SC; Her E; Kim SH; Kang CD
J Ethnopharmacol; 2010 Jul; 130(2):248-54. PubMed ID: 20438825
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell growth and induction of apoptosis in human prostate cancer cell lines by 6-aminoquinolone WM13.
Minelli A; Bellezza I; Siciliano E; Liguori L; Tabarrini O; Cecchetti V; Fravolini A
Oncol Rep; 2005 Jun; 13(6):1113-20. PubMed ID: 15870930
[TBL] [Abstract][Full Text] [Related]
14. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.
Yang Y; Ikezoe T; Takeuchi T; Adachi Y; Ohtsuki Y; Koeffler HP; Taguchi H
Oncol Rep; 2006 Jun; 15(6):1581-90. PubMed ID: 16685399
[TBL] [Abstract][Full Text] [Related]
15. Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.
Xia Q; Sung J; Chowdhury W; Chen CL; Höti N; Shabbeer S; Carducci M; Rodriguez R
Cancer Res; 2006 Jul; 66(14):7237-44. PubMed ID: 16849572
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines.
Mahoney S; Arfuso F; Rogers P; Hisheh S; Brown D; Millward M; Dharmarajan A
J Biosci; 2012 Mar; 37(1):73-84. PubMed ID: 22357205
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells.
McPherson RA; Galettis PT; de Souza PL
Br J Cancer; 2009 Feb; 100(4):649-55. PubMed ID: 19209173
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis.
Vinall RL; Hwa K; Ghosh P; Pan CX; Lara PN; de Vere White RW
Clin Cancer Res; 2007 Oct; 13(20):6204-16. PubMed ID: 17947488
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer.
Kaseb AO; Chinnakannu K; Chen D; Sivanandam A; Tejwani S; Menon M; Dou QP; Reddy GP
Cancer Res; 2007 Aug; 67(16):7782-8. PubMed ID: 17699783
[TBL] [Abstract][Full Text] [Related]
20. A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species.
Chen HM; Chang FR; Hsieh YC; Cheng YJ; Hsieh KC; Tsai LM; Lin AS; Wu YC; Yuan SS
Free Radic Biol Med; 2011 May; 50(9):1151-62. PubMed ID: 21256211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
